PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease ReportsSleep wake disorders
MeSH D012893 - sleep wake disorders
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D009461:Neurologic manifestations
32 Companies
3 Drugs
$
Success rate
D001523:Mental disorders
0 Companies
0 Drugs
Success rate
D009422:Nervous system diseases
1 Company
1 Drug
$
Success rate
D012893: 
Sleep wake disorders
7 Companies
1 Drug
$
Success rate
D012892:Sleep deprivation
0 Companies
0 Drugs
Success rate
D020447:Parasomnias
0 Companies
0 Drugs
Success rate
D020920:Dyssomnias
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
AllerganArmodafinil Armodafinil  2012-08-29   
Aurobindo PharmaArmodafinil Armodafinil  2018-03-06   
CorePharmaArmodafinil Armodafinil  2019-03-25   
Lupin ResearchArmodafinil Armodafinil  2016-11-28   
MylanArmodafinil Armodafinil  2012-06-01   
NATCO PharmaArmodafinil Armodafinil  2016-11-28   
Nuvo PharmaceuticalsArmodafinil Nuvigil 2023-11-29 2007-06-15   
Clinical Trials
Historical Success Rate
Phase 1
33%
2/6
Phase 2
50%
7/14
Phase 3
27%
4/15
Approved: 1Overall Success rate: 4%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Mylan
Bevifimod
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use